Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raphael Ferreira, Ph.D.

Concepts (38)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Raphael Ferreira's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Raphael Ferreira has written about over time.
Endodeoxyribonucleases, 1 publications between 2020 and 2020, average publication date May 2020. Retroelements, 1 publications between 2020 and 2020, average publication date May 2020. Asymptomatic Infections, 1 publications between 2021 and 2021, average publication date January 2021. Brain Neoplasms, 1 publications between 2021 and 2021, average publication date March 2021. False Positive Reactions, 2 publications between 2021 and 2021, average publication date May 2021. DNA Contamination, 1 publications between 2021 and 2021, average publication date September 2021. DNA, Viral, 1 publications between 2021 and 2021, average publication date September 2021. Cell Culture Techniques, 1 publications between 2023 and 2023, average publication date September 2023. High-Throughput Screening Assays, 1 publications between 2023 and 2023, average publication date September 2023. Cell Differentiation, 1 publications between 2024 and 2024, average publication date May 2024. DNA Replication, 1 publications between 2024 and 2024, average publication date May 2024. Nucleotides, 1 publications between 2024 and 2024, average publication date May 2024. S Phase, 1 publications between 2024 and 2024, average publication date May 2024.

To see the data from this visualization as text, click here.
Ferreira's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (38)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.